Abstract Search

ea0049ep899 | Neuroendocrinology | ECE2017

Endogenous Cushing’s syndrome ( clinical and biochemical features in a large cohort of patients

Vilar Lucio , Vilar Clarice , Albuquerque Jose Luciano , Trovao Erik , The Ana Carolina , Gadelha Patricia , Melo Maira , Gomes Barbara , Borges Thaise , Cardoso Izabela , Lyra Ruy

Patients and methods: We retrospectively analysed the clinical and biochemical characteristics of a cohort of 150 patients with endogenous Cushings syndrome (CS). Cushings disease (CD) accounted for 61.3% of cases (n=92), ectopic ACTH secretion (EAS) 7.3% (n=11), and adrenal diseases 31.3% (n=47). Among CD cases, there were 19 macroadenomas (20.6%), a female predominance (60.5%) and a median age of 33 years old (range 1455). Bronchi...

1 shares

ea0056p882 | Pituitary - Clinical | ECE2018

Efficacy and tolerability of cabergoline in a cohort of 160 prolactinomas at weekly doses of up to 9 mg

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , The Ana Carolina , Trovao Erik , Gadelha Patricia , Sampaio Icaro , Gomes Barbara , Ferreira Liana , Aroucha Priscila , Lyra Raissa , Fonseca Maira , Lyra Ruy

Background: Dopamine agonists are the mainstay of treatment for prolactinomas. Cabergoline (CAB) is preferable to bromocriptine due to its greater efficacy and better tolerability.Subjects and methods: The aim of this retrospective open trial was to evaluate the efficacy and tolerability of CAB in a cohort of 160 patients with prolactinomas routinely followed in Pernambuco Endocrine Research Center and Division of Endocrinology, Hospital das Clinicas, Fe...

0 shares

Endocrine Abstracts

Endogenous Cushing’s syndrome ( clinical and biochemical features in a large cohort of patients

Efficacy and tolerability of cabergoline in a cohort of 160 prolactinomas at weekly doses of up to 9 mg

BiosciAbstracts